Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
暂无分享,去创建一个
[1] P. Seth,et al. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. , 1996, Cancer research.
[2] H. Fine,et al. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. , 1995, The Journal of clinical investigation.
[3] J. Dick,et al. A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Ghalie,et al. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. , 1995, Experimental hematology.
[5] D. Kohn,et al. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. , 1995, Blood.
[6] J. Roth,et al. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. , 1995, BioTechniques.
[7] H. Fine,et al. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. , 1994, Cancer research.
[8] G. Nemerow,et al. Multiple adenovirus serotypes use alpha v integrins for infection , 1994, Journal of virology.
[9] K. Sikora,et al. Gene therapy for cancer using tumour-specific prodrug activation. , 1994, Gene therapy.
[10] N. Davidson,et al. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide. , 1994, Cancer research.
[11] H. Juhl,et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] S. Ethier,et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] O. Fodstad,et al. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow. , 1994, Cancer research.
[14] N. Davidson,et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. , 1993, Blood.
[15] R. Vile,et al. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. , 1993, Cancer research.
[16] G. Rosner,et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Pasqualini,et al. A study of the structure, function and distribution of beta 5 integrins using novel anti-beta 5 monoclonal antibodies. , 1993, Journal of cell science.
[18] G. Nemerow,et al. Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment , 1993, Cell.
[19] R. Gerard,et al. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Vile,et al. In vitro and in vivo targeting of gene expression to melanoma cells. , 1993, Cancer research.
[21] D. Kufe,et al. Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Nabel,et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. , 1992, Human gene therapy.
[23] G. Bastert,et al. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] B. Teicher,et al. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Ian Magrath,et al. A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range: Application to quantitation of β-galactosidase in lacZ-transfected cells , 1991 .
[26] M L Lesser,et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] C. Richards,et al. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Wilson,et al. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. , 1991, The Journal of biological chemistry.
[29] R. Beveridge,et al. High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. , 1991, Journal of the National Cancer Institute.
[30] R. Bast,et al. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. , 1991, Bone marrow transplantation.
[31] G. Pelosi,et al. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow , 1991, Cancer.
[32] G. Rosner,et al. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] I. Magrath,et al. A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: application to quantitation of beta-galactosidase in lacZ-transfected cells. , 1991, Analytical biochemistry.
[34] F. Graham,et al. Manipulation of adenovirus vectors. , 1991, Methods in molecular biology.
[35] D. Hayes,et al. Detection and characterization of a high molecular weight human lung carcinoma-associated glycoprotein. , 1990, Cancer research.
[36] E. Nabel,et al. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. , 1990, Science.
[37] C. Eaves,et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Hayes,et al. Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow. , 1990, Cancer research.
[39] R. Bast,et al. Elimination of malignant clonogenic breast cancer cells from human bone marrow. , 1989, Cancer research.
[40] C. Wu,et al. Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.
[41] R. Bast,et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] G P Nolan,et al. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[43] D. Hayes,et al. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas. , 1986, Cancer research.
[44] J. Schlom,et al. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. , 1984, Hybridoma.
[45] C. Taswell,et al. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.
[46] F. Graham,et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.
[47] O. Heinisch,et al. Steel, R. G. D., and J. H. Torrie: Principles and Procedures of Statistics. (With special Reference to the Biological Sciences.) McGraw‐Hill Book Company, New York, Toronto, London 1960, 481 S., 15 Abb.; 81 s 6 d , 1962 .
[48] F. N. David,et al. Principles and procedures of statistics. , 1961 .